Chao Li, Ph.D. is a Staff Scientist in the Molecular Neuropathology Group at the Institute. Her research interest focuses primarily on Williams Syndrome gene regulation, expression and alternative splicing in the human postmortem brain. Dr. Li received her B.S. and Ph.D. in Biochemistry and Molecular Biology in College of Life Science & Biotechnology of Shanghai Jiao Tong University in China in 2007. Prior to joining the Lieber Institute, she was a postdoctoral fellow in the Genes Cognition and Psychosis Program (GCAP) of the National Institute of Mental Health.